Trial design-CX6

INNOVATV 204/GOG-3023/ENGOT-CX6

Clinical Trial Study: CX6

A Single arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer.

Study design